Navigation Links
Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
Date:11/2/2007

University of Florida, Gainesville, and a lead investigator in this Phase IIb study.

About Hepatitis C

Hepatitis C is a blood-borne infectious disease of the liver and a leading cause of cirrhosis, liver cancer and the need for liver transplants. According to the Centers for Disease Control and Prevention (CDC), an estimated 4.1 million Americans (1.6 percent) have been infected with hepatitis C; 3.2 million are chronically infected. The number of new infections per year has declined from an average of 240,000 in the 1980s to about 26,000 in 2004. CDC estimates the number of hepatitis C-related deaths could increase to 38,000 annually by the year 2010, surpassing annual HIV/AIDS deaths.

About PEGASYS

PEGASYS, in combination with COPEGUS (ribavirin), are indicated for the treatment of adults with chronic hepatitis C who have compensated liver disease and have not previously been treated with interferon alpha. Efficacy has been demonstrated in patients with compensated liver disease and histological evidence of cirrhosis (Child-Pugh class A) and patients with HIV disease that are clinically stable (e.g., antiretroviral therapy not required or receiving stable antiretroviral therapy). In addition, PEGASYS in combination with COPEGUS is the first and only FDA-approved regimen for the treatment of chronic hepatitis C in patients coinfected with hepatitis C and HIV. PEGASYS is the only pegylated interferon indicated for the treatment of adult patients with chronic hepatitis B (HBeAg positive and HBeAg negative chronic hepatitis B who have compensated liver disease and evidence of viral replication and liver inflammation).

PEGASYS is dosed at 180mcg as a subcutaneous injection taken once a week. COPEGUS is available as a 200mg tablet, and is administered orally two times a day as a split dose. Roche has backed PEGASYS with the most extensive clinical research program ever undertaken in hepatitis C, with major studies initiated to advance treat
'/>"/>

SOURCE Roche
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
5. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
6. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
7. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
11. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... VIEJO, Calif. , Nov. 26, 2014 /PRNewswire/ ... announced that the U.S. Food and Drug Administration ... its New Drug Application (NDA) for AVP-825. AVP-825 ... low-dose sumatriptan powder delivered intranasally utilizing a novel ... the Complete Response letter, and consistent with the ...
(Date:11/26/2014)... , November 26, 2014 Investor-Edge has ... VVUS ), Horizon Pharma PLC (NASDAQ: HZNP ... Johnson (NYSE: JNJ ), and Theravance Inc. (NASDAQ: ... can be accessed at: http://investor-edge.com/register . On ... up 0.07%, the Dow Jones Industrial Average edged 0.02% lower, ...
(Date:11/26/2014)... Nov. 26, 2014  BioScrip ® , Inc. (NASDAQ: ... and Chief Executive Officer, will present at the Bank of America ... , , Date: , , , Wednesday, December 3, 2014 ... EST , , , , Location: , , , Boca ... About BioScrip, Inc. BioScrip, Inc. is a ...
Breaking Medicine Technology:Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 2Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5
... Four novel genes that may,significantly increase the ... have been identified by researchers at Massachusetts General,Hospital ... November 7th issue,of American Journal of Human Genetics. ... (AGP) established three years ago to identify,the full ...
... FREMONT, Calif., Oct. 29 Vermillion, Inc.,(OTC Bulletin ... with Quest,Diagnostics to extend the Strategic Alliance Agreement ... enable the companies to continue,work on the development ... The OVA1 test is intended to identify women ...
Cached Medicine Technology:Breakthrough Mapping of Alzheimer's Genome Helps ID Four New Suspect Genes 2Breakthrough Mapping of Alzheimer's Genome Helps ID Four New Suspect Genes 3Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc. 2Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc. 3Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc. 4
(Date:11/28/2014)... 2014 Lunadress.co.uk, one of the world’s ... has recently released its fashionable white prom gowns. These ... quality and low price. The company provides a big ... and free shipping for orders over 99 pounds. , ... professional sales representatives if needed. The kind experts will ...
(Date:11/28/2014)... 2014 The report “Poxvirus Infections ... the therapeutic development for Poxvirus Infections, complete with ... drug target, mechanism of action (MoA), route of ... updates, and featured news and press releases. It ... development for Poxvirus Infections and special features on ...
(Date:11/28/2014)... Angelweddingdress.com, a world-famous dress manufacturer and retailer, has ... Styles of Bridesmaid Dresses recently. A big ... free shipping on orders over $150! Those who ... less at the online store please click ... reliable dress supplier in the international market. It ...
(Date:11/28/2014)... Yesterday on November 27th, 2014, Thanksgiving morning, ... and families from 8 different sites throughout Miami-Dade and ... in Florida on Thanksgiving Day. Over 1,400 volunteers worked ... together individual meals via assembly lines and passing them ... includes turkey, stuffing, green beans, mashed potatoes, cranberry sauce, ...
(Date:11/28/2014)... 2014 Pathways Home Health & ... This national movement was created to encourage people to ... local charities and causes. This online event, celebrated ... kickoff of the holiday shopping season. #GivingTuesday is to ... Cyber Monday is to online commerce. , The goal ...
Breaking Medicine News(10 mins):Health News:LunaDress.co.uk: New White LunaDress Prom Gowns Online for Sale Now 2Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 2Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 3Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 4Health News:Blue Color Styles of Bridesmaid Dresses from AngelWeddingDress.com are Available Now With Big Discounts 2Health News:Branches’ 14th Annual Thanksgiving Delivers 6,000+ Meals to Families in Need 2Health News:Pathways Home Health & Hospice Joins #GivingTuesday; Annual Holiday Encourages Local Charitable Giving 2Health News:Pathways Home Health & Hospice Joins #GivingTuesday; Annual Holiday Encourages Local Charitable Giving 3
... HealthDay Reporter , MONDAY, March 5 (HealthDay News) -- The more ... big screen, the more alcohol they drink themselves, a new study ... 10 to 19 from six European countries -- the largest study ... or more drinks on at least one occasion. Teens who ...
... , MONDAY, March 5 (HealthDay News) -- Babies ... greater risk of developing asthma when compared with children born ... to infants born between the 34th and 37th week of ... an asthma diagnosis by the age of 8 years, despite ...
... available in French . A ... increase in prevalence of Canadian children diagnosed with attention-deficit ... associated with ADHD in school-age children. The study, ... Among Canadian Preschoolers and School-Age Children: 1994-2007, was conducted ...
... study from Case Western Reserve University,s Frances Payne Bolton ... related to quality of life before becoming critically ill. ... a research team that observed, taped and analyzed discussions ... intensive care units (ICUs) at University Hospitals Case Medical ...
... gene that causes adult-onset primary cervical dystonia, an often-painful condition ... team from the Jacksonville, Fla., campus of Mayo Clinic and ... a movement disorder that physicians previously could seldom explain. Their ... . In 1990, a man with a crooked neck ...
... University of Notre Dame,s annual Bengal Bouts student boxing ... Bodies May Be Nourished." The unusual mantra is ... benefit Holy Cross Missions in Bangladesh, part of the ... Dame,s founding religious community. However, this year a large ...
Cached Medicine News:Health News:Drinking Scenes in Movies May Spur Teens to Do the Same 2Health News:Drinking Scenes in Movies May Spur Teens to Do the Same 3Health News:Late Preemie Birth May Be Linked to Higher Asthma Risk 2Health News:Hyperactivity: Increased prevalence of children with ADHD and the use of stimulants 2Health News:CWRU study finds quality-of-life discussions are important for ICU patients 2Health News:Researchers ID gene behind primary cervical dystonia, a neck-twisting disorder 2Health News:Researchers ID gene behind primary cervical dystonia, a neck-twisting disorder 3Health News:Notre Dame's Bengal Bouts participants aid in concussion research 2Health News:Notre Dame's Bengal Bouts participants aid in concussion research 3
... This contact class is ... slit lamps which have a ... and the reduction prism than ... area: fundus / iridocornea. Mirror ...
... Fully Automatic High Speed Pre and Post ... a double-wall autoclave designed to cover a ... operating rooms, as well as private clinics ... designed for sterilization of medical and surgical ...
HRT II is the smallest scanning laser ever, light, portable and ready for telemedicine....
Subjective refraction unit, computer controlled and programmable. Two versions: with and without prisms....
Medicine Products: